353810.KQ
EASY BIO,Inc.
KOE · Healthcare · Biotechnology · KR
KRW 6,290.00
−2.33%Year over year
Reported trailing growth
- Revenue
- +15.5%
- EBITDA
- -32.0%
- EBIT
- +40.5%
- EPS
- +101.8%
- Free cash flow
- +90.9%
- Operating cash flow
- +109.5%
Forward estimates
Based on analyst estimates
- Revenue
- -50.5%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +45.3%
- EBITDA
- +47.0%
- EBIT
- +40.7%
- Net income
- +44.9%
- EPS
- +46.4%
- Free cash flow
- -4.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026